CATALOGO DEI PRODOTTI DELLA RICERCA

CIPRIANI, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.531
NA - Nord America 8.397
AS - Asia 5.528
SA - Sud America 1.012
AF - Africa 78
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 11
Totale 23.582
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.278
RU - Federazione Russa 2.740
SG - Singapore 2.537
GB - Regno Unito 2.340
CN - Cina 1.581
BR - Brasile 839
IT - Italia 832
FR - Francia 586
HK - Hong Kong 517
FI - Finlandia 476
DE - Germania 460
VN - Vietnam 400
IE - Irlanda 385
SE - Svezia 346
UA - Ucraina 156
KR - Corea 143
AR - Argentina 71
CA - Canada 64
TR - Turchia 54
ID - Indonesia 51
NL - Olanda 46
IN - India 42
JP - Giappone 37
MX - Messico 35
BD - Bangladesh 33
EC - Ecuador 27
AT - Austria 24
AU - Australia 22
ES - Italia 22
PL - Polonia 22
IL - Israele 21
ZA - Sudafrica 19
RO - Romania 18
BE - Belgio 17
IQ - Iraq 16
PY - Paraguay 16
UY - Uruguay 15
PK - Pakistan 14
CO - Colombia 13
PE - Perù 13
KE - Kenya 12
EG - Egitto 11
MA - Marocco 10
CH - Svizzera 9
EU - Europa 9
CL - Cile 8
HU - Ungheria 8
JO - Giordania 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
DZ - Algeria 7
KZ - Kazakistan 7
VE - Venezuela 7
GR - Grecia 6
UZ - Uzbekistan 6
BG - Bulgaria 5
BY - Bielorussia 5
HN - Honduras 5
IR - Iran 5
PH - Filippine 5
PT - Portogallo 5
SA - Arabia Saudita 5
TN - Tunisia 5
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
AM - Armenia 3
BN - Brunei Darussalam 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
GT - Guatemala 3
LB - Libano 3
LT - Lituania 3
SI - Slovenia 3
AO - Angola 2
BO - Bolivia 2
ET - Etiopia 2
JM - Giamaica 2
KG - Kirghizistan 2
KH - Cambogia 2
KW - Kuwait 2
LU - Lussemburgo 2
MN - Mongolia 2
MY - Malesia 2
NG - Nigeria 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
RS - Serbia 2
SC - Seychelles 2
TH - Thailandia 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BW - Botswana 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GF - Guiana Francese 1
Totale 23.566
Salva come PNG Salva come JPEG
Città #
Southend 2.103
Jacksonville 1.298
Singapore 1.249
Woodbridge 967
Chandler 841
Moscow 738
Dallas 677
Ann Arbor 580
Houston 552
Hong Kong 514
Ashburn 401
Dublin 385
Beijing 260
Wilmington 222
Lawrence 216
Princeton 216
The Dalles 179
Verona 155
New York 153
Ho Chi Minh City 134
Nanjing 128
Los Angeles 113
Jinan 111
Shenyang 104
Buffalo 100
Milan 96
Hebei 73
São Paulo 73
Hanoi 71
Redondo Beach 61
Munich 58
Dong Ket 56
Helsinki 52
Tianjin 51
Changsha 49
Sindelfingen 47
Nanchang 45
Rome 44
Haikou 40
Boardman 39
Hangzhou 36
Ningbo 36
Guangzhou 35
Columbus 34
Washington 34
Norwalk 31
Dearborn 30
Redwood City 30
Santa Clara 29
Taiyuan 29
Zhengzhou 29
Bologna 26
Jiaxing 26
Tokyo 26
London 25
San Francisco 25
Taizhou 25
Turku 24
Toronto 23
Council Bluffs 21
Lancaster 21
Belo Horizonte 20
Rio de Janeiro 19
Brasília 18
Chicago 18
Stockholm 18
Jakarta 17
Manchester 17
Mexico City 17
Shanghai 16
Florence 15
Fuzhou 15
Montreal 15
Orem 15
San Jose 15
Warsaw 15
Brooklyn 14
Brussels 14
Nuremberg 14
Düsseldorf 13
Falls Church 13
Frankfurt am Main 13
Haiphong 13
Montevideo 13
Porto Alegre 13
Campinas 12
Lanzhou 12
Vienna 12
Amsterdam 11
Chennai 11
Curitiba 11
Guayaquil 11
Naples 11
Atlanta 10
Lima 10
Nairobi 10
Seattle 10
Ankara 9
Asunción 9
Da Nang 9
Totale 14.374
Salva come PNG Salva come JPEG
Nome #
Efficacia del litio nella depressione resistente con rischio suicidario. Studio indipendente, pragmatico, multicentrico, di superiorità 523
Efficacia del litio nella depressione resistente con rischio suicidario. Studio indipendente, pragmatico, multicentrico, di superiorità 386
[(123)I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism. 282
[Randomized trials, systematic reviews, meta-analyses: basic criteria in the world of scientific evidence]. 221
Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial 201
Assessing risk of bias in randomized controlled trials 183
Antidepressants and benzodiazepines for panic disorder in adults 181
Development of a registry for monitoring psychotropic drug prescriptions: Aims, methods and implications for ordinary practice and research 178
"Wish bias" in antidepressant drug trials? 173
Allocation concealment and blinding in clinical trials 171
Adding aripiprazole improves major depressive disorder following incomplete response to antidepressants alone 171
Commentary: Haloperidol, risperidone and olanzapine are similarly effective for first-episode non-affective psychosis but have differing side effects 168
Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia: a 12-month, randomized, naturalistic trial 166
Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia 166
Antidepressant drug prescription and risk of abnormal bleeding. A case-control study 165
Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: results and lessons of an underpowered randomised clinical trial 165
An approach for modelling multiple correlated outcomes in a network of interventions using odds ratios 164
Antidepressive Monotherapie 163
Trasformare la pratica clinica in ricerca. Un invito a partecipare allo studio CHAT 162
Effect of antipsychotic drugs on cerebrovascular morbidity and mortality: a systematic review 157
Agomelatine and the brave old world of narrative-based medicine 157
Trazodone nell'anziano con problemi di insonnia: quale il razionale? 155
Comparison of systematic and narrative reviews: the example of the atypical antipsychotics 152
Adherence therapy does not improve quality of life in people with schizophrenia [Comment] 149
Agomelatine efficacy and acceptability revisited: systematic review and meta-analysis of published and unpublished randomised trials 147
Commentary: Antipsychotic plus mood stabiliser co-therapy is more effective than mood stabiliser mono-therapy at reducing acute bipolar mania 145
What is a run-in phase? 145
Azapirones versus placebo for panic disorder in adults 145
Implementation of treatment guidelines for specialist mental health care 145
Are all antidepressants really the same? The case of fluoxetine: a systematic review 143
Citalopram versus other anti-depressive agents for depression 142
Sertraline versus other antidepressive agents for depression 142
A primer on network meta-analysis with emphasis on mental health 142
Antidepressants for Bipolar Disorder 141
Citalopram versus other anti-depressive agents for depression 141
A fully Bayesian application of the Copas selection model for publication bias extended to network meta-analysis 141
Antipsychotic drugs and cerebrovascular events in elderly patients with dementia: a systematic review 140
Antidepressants and suicide symptoms: compelling new insights from the FDA's analysis of individual patient level data 139
Benzodiazepines and risk of dementia: true association or reverse causation? 139
Efficacy of selective serotonin reuptake inhibitors and adverse events: meta-regression and mediation analysis of placebo-controlled trials 139
Associazione tra TCA e SSRI nella depressione resistente 138
Understanding antipsychotic non-classical prescriptions: a quantitative and qualitative approach 137
Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: a protocol for a randomised, independent, pragmatic, multicentre, parallel-group, superiority clinical trial 137
Imputing missing standard deviations in meta-analyses can provide accurate results 136
Randomized trials published in Chinese or Western journals: comparative empirical analysis 136
Allowing for uncertainty due to missing continuous outcome data in pairwise and network meta-analysis 136
What is a systematic review? 135
Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis 134
Efficacy of pharmacotherapy against core traits of borderline personality disorder: Meta-analysis of randomized controlled trials 132
Trasformare la pratica clinica in ricerca. Un invito a partecipareallo studio CHAT. 132
Antidepressants in unipolar major depression: what we need to know 132
Duloxetine versus other anti-depressive agents for depression 131
Seven criteria for improving effectiveness trials in psychiatry 128
Citalopram versus other anti-depressive agents for depression. 128
Profilo di efficacia e tollerabilità dell'escitalopram rispetto agli altri farmaci antidepressivi nel trattamento acuto della depressione maggiore: revisione sistematice e meta-analisi. [Efficacy and tolerability profile of escitalopram versus other antidepressants in the acute treatment of major depressive disorder: A systematic review and meta-analysis] 127
What is a forest plot? 126
What is a risk ratio? 126
Levels of evidence: can quality of systematic reviews be quantified? 126
Selective serotonin reuptake inhibitors and risk of suicide: A systematic review of observational studies 126
Implementation of treatment guidelines for specialist mental health care 126
A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development 126
Persistence with pharmacological treatment in the specialist mental healthcare of patients with severe mental disorders 125
Advancing evidence-based practice to improve patient care 123
Beneficial and adverse effects of antidepressants on suicide mortality in individuals with major depression 122
Depressive disorders 121
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis 121
Implementation of treatment guidelines for specialist mental health care 121
Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology 119
Conventional vs. atypical antipsychotic medications [Letter] 118
Benzodiazepine use in the real world of psychiatric practice: low-dose, long-term drug taking and low rates of treatment discontinuation 118
Use of antipsychotic drugs and mood stabilizers in women of childbearing age with schizophrenia and bipolar disorder: epidemiological survey. 118
Paroxetine versus other anti-depressive agents for depression 117
Comparative efficacy and acceptability of antimanic drugsin acute mania: a multiple-treatments meta-analysis 116
Sertraline versus other antidepressive agents for depression 115
Superiority, equivalence or non-inferiority? 114
Psychological therapies versus pharmacotherapy for obsessive compulsive disorder (Protocol) 114
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis 114
Outcome reporting bias in clinical trials 113
Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials 113
Fluoxetine versus other types of pharmacotherapy for depression (Review) 112
Dalle revisioni narrative a quelle sitematiche e alle metanalisi, per un approccio moderno alla valutazione dei trattamenti farmacologici in psichiatria 110
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: A 2-year follow-up multicenter study. 110
Does the addiction of a second antipsychotic drug improve clozapine treatment? 109
What is a clinical trial protocol? 109
What is an individual patient data meta-analysis? 108
Forensic database study suggests selective serotonin reuptake inhibitors do not increase the risk of suicide in people taking antidepressants 107
Impact of regulatory changes on first- and second-generation antipsychotic drug consumption and expenditure in Italy 107
Mirtazapine versus other antidepressive agents for depression 105
What is a factorial trial? 104
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis 104
Commentary on: Analysis and reporting of factorial trials: a systematic review (McAlister et al., JAMA) 103
Validity of the impact factor of journals as a measure of randomised controlled trial quality 103
Review: atypical antipsychotics are effective adjuncts for treatment resistant depression but increase discontinuation due to adverse effects 103
Risk of suicidal behaviour in adults taking antidepressants 103
Haloperidol alone or in combination for acute mania 102
What is a randomised controlled trial? 102
What is an intention to treat analysis? 102
Olanzapine in long-term treatment for bipolar disorder (Protocol for a Cochrane Review) 101
What is a multiple treatments meta-analysis? 101
Fluoxetine versus other types of pharmacotherapy for depression (Protocol for a Cochrane Review) 100
Totale 14.117
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.070
article - articoli 75.145
book - libri 352
conference - conferenze 0
curatela - curatele 0
other - altro 2.046
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.527
Totale 160.140
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021741 0 0 0 0 0 192 18 147 127 23 137 97
2021/20221.254 72 282 25 57 42 29 12 91 60 31 140 413
2022/20232.732 253 166 332 431 290 572 33 183 320 30 70 52
2023/20241.351 71 129 111 118 162 187 47 92 19 83 190 142
2024/20253.814 285 251 171 554 177 137 216 178 566 280 225 774
2025/20266.498 768 624 838 1.487 2.201 580 0 0 0 0 0 0
Totale 23.710